Literature DB >> 21586567

The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.

Moustapha Cissé1, Eric Duplan, Marie-Victoire Guillot-Sestier, Joaquim Rumigny, Charlotte Bauer, Gilles Pagès, Hans-Dieter Orzechowski, Barbara E Slack, Frédéric Checler, Bruno Vincent.   

Abstract

The α-secretases A disintegrin and metalloprotease 10 (ADAM10) and ADAM17 trigger constitutive and regulated processing of the cellular prion protein (PrP(c)) yielding N1 fragment. The latter depends on protein kinase C (PKC)-coupled M1/M3 muscarinic receptor activation and subsequent phosphorylation of ADAM17 on its intracytoplasmic threonine 735. Here we show that regulated PrP(c) processing and ADAM17 phosphorylation and activation are controlled by the extracellular-regulated kinase-1/MAP-ERK kinase (ERK1/MEK) cascade. Thus, reductions of ERK1 or MEK activities by dominant-negative analogs, pharmacological inhibition, or genetic ablation all impair N1 secretion, whereas constitutively active proteins increase N1 recovery in the conditioned medium. Interestingly, we also observed an ERK1-mediated enhanced expression of PrP(c). We demonstrate that the ERK1-associated increase in PrP(c) promoter transactivation and mRNA levels involve transcription factor AP-1 as a downstream effector. Altogether, our data identify ERK1 as an important regulator of PrP(c) cellular homeostasis and indicate that this kinase exerts a dual control of PrP(c) levels through transcriptional and post-transcriptional mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586567      PMCID: PMC3190726          DOI: 10.1074/jbc.M110.208249

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Isoform-specific contribution of protein kinase C to prion processing.

Authors:  Moustapha Alfa Cissé; Krystel Louis; Uschi Braun; Bernard Mari; Michael Leitges; Barbara E Slack; Abraham Fisher; Patrick Auberger; Frédéric Checler; Bruno Vincent
Journal:  Mol Cell Neurosci       Date:  2008-07-29       Impact factor: 4.314

2.  Axonal prion protein is required for peripheral myelin maintenance.

Authors:  Juliane Bremer; Frank Baumann; Cinzia Tiberi; Carsten Wessig; Heike Fischer; Petra Schwarz; Andrew D Steele; Klaus V Toyka; Klaus-Armin Nave; Joachim Weis; Adriano Aguzzi
Journal:  Nat Neurosci       Date:  2010-01-24       Impact factor: 24.884

3.  Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1.

Authors:  Fabiana A Caetano; Marilene H Lopes; Glaucia N M Hajj; Cleiton F Machado; Camila Pinto Arantes; Ana C Magalhães; Mônica De Paoli B Vieira; Tatiana A Américo; Andre R Massensini; Suzette A Priola; Ina Vorberg; Marcus V Gomez; Rafael Linden; Vania F Prado; Vilma R Martins; Marco A M Prado
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

4.  The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo.

Authors:  Marie-Victoire Guillot-Sestier; Claire Sunyach; Charlotte Druon; Sabine Scarzello; Frédéric Checler
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

5.  ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε.

Authors:  Moustapha Cisse; Ursula Braun; Michael Leitges; Abraham Fisher; Gilles Pages; Frédéric Checler; Bruno Vincent
Journal:  Mol Cell Neurosci       Date:  2011-05-04       Impact factor: 4.314

6.  Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1.

Authors:  Shayne A Bellingham; Louise A Coleman; Colin L Masters; James Camakaris; Andrew F Hill
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

7.  Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion.

Authors:  Oriol Nicolas; Rosalina Gavín; Nathalie Braun; Jesús Mariano Ureña; Xavier Fontana; Eduardo Soriano; Adriano Aguzzi; José Antonio del Río
Journal:  FASEB J       Date:  2007-05-10       Impact factor: 5.191

Review 8.  Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer.

Authors:  Tarek Boutros; Eric Chevet; Peter Metrakos
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

9.  Identification of adjacent binding sites for the YY1 and E4BP4 transcription factors in the ovine PrP (Prion) gene promoter.

Authors:  Stewart T G Burgess; Cuicui Shen; Laura A Ferguson; Gerard T O'Neill; Kevin Docherty; Nora Hunter; Wilfred Goldmann
Journal:  J Biol Chem       Date:  2009-01-07       Impact factor: 5.157

Review 10.  Physiology of the prion protein.

Authors:  Rafael Linden; Vilma R Martins; Marco A M Prado; Martín Cammarota; Iván Izquierdo; Ricardo R Brentani
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

View more
  12 in total

1.  Two-steps control of cellular prion physiology by the extracellular regulated kinase-1 (ERK1).

Authors:  Frédéric Checler
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

2.  Alzheimer's and prion diseases: PDK1 at the crossroads.

Authors:  Frédéric Checler
Journal:  Nat Med       Date:  2013-09       Impact factor: 53.440

3.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

4.  α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death.

Authors:  Marie-Victoire Guillot-Sestier; Claire Sunyach; Sergio T Ferreira; Maria-Paz Marzolo; Charlotte Bauer; Aurélie Thevenet; Frédéric Checler
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

Review 5.  Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy.

Authors:  Michael Nehls
Journal:  J Mol Psychiatry       Date:  2016-07-15

6.  An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice.

Authors:  Yvette I Sheline; Tim West; Kevin Yarasheski; Robert Swarm; Mateusz S Jasielec; Jonathan R Fisher; Whitney D Ficker; Ping Yan; Chengjie Xiong; Christine Frederiksen; Monica V Grzelak; Robert Chott; Randall J Bateman; John C Morris; Mark A Mintun; Jin-Moo Lee; John R Cirrito
Journal:  Sci Transl Med       Date:  2014-05-14       Impact factor: 17.956

Review 7.  α-Cleavage of cellular prion protein.

Authors:  Jingjing Liang; Qingzhong Kong
Journal:  Prion       Date:  2012-10-10       Impact factor: 3.931

8.  Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analogues.

Authors:  Hongyun Li; Genevieve Evin; Andrew F Hill; Ya Hui Hung; Ashley I Bush; Brett Garner
Journal:  Clin Sci (Lond)       Date:  2012-05       Impact factor: 6.124

9.  The Prion Protein N1 and N2 Cleavage Fragments Bind to Phosphatidylserine and Phosphatidic Acid; Relevance to Stress-Protection Responses.

Authors:  Cathryn L Haigh; Carolin Tumpach; Simon C Drew; Steven J Collins
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 10.  ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?

Authors:  Roser Buscà; Jacques Pouysségur; Philippe Lenormand
Journal:  Front Cell Dev Biol       Date:  2016-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.